UCB Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al
| UCB Inc., UCB Biopharma SPRL, Research Corporation Technologies Inc. and Harris FRC Corporation |
| Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. |
| 1:2016cv00903 |
| October 6, 2016 |
| US District Court for the District of Delaware |
| Wilmington Office |
| XX US, Outside State |
| Leonard P. Stark |
| Patent |
| 35 U.S.C. ยง 271 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
13
MEMORANDUM ORDER - Defendants' motion (D.I. 7 ) is GRANTED IN PART and DENIED IN PART; (i) this case is STAYED until the earlier of: (a) the Federal Circuit's issuance of a decision in the Accord Appeal, or (b) January 31, 2018; an d (ii) the parties shall advise the Court no later than the earlier of (a) seven (7) days after the issuance of a decision from the Federal Circuit in the Accord Appeal, or (b) January 24, 2018, of their position(s) as to how this case should proceed. Signed by Judge Leonard P. Stark on 9/28/2017. (etg)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
